Published in Medical Patent Business Week, June 22nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Ranbaxy Laboratories.
Report 1: Ranbaxy Laboratories Limited announced today that, Dr. Himadri Sen will be joining the company as President - R&D (Generics & NDDS). Dr. Sen is widely regarded for his professional acumen and is a highly respected figure in the pharmaceutical industry with an illustrious and successful international career, spanning over three decades.
Welcoming Dr. Sen to Ranbaxy, Malvinder Singh, CEO and MD, Ranbaxy said, "We are very pleased to renew our close...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.